Probiotics in prevention and treatment of cardiovascular diseases

Increasing knowledge of the gut microbiota and its interference in human homeostasis in recent years has contributed to a better understanding of number of different interactions occurring in the gastrointestinal tract. Disruption of the microbiota is detrimental to health and contributes to the dev...

Full description

Bibliographic Details
Main Authors: Przerwa Filip, Kukowka Arnold, Kotrych Katarzyna, Uzar Izabela
Format: Article
Language:English
Published: Polish Ministry of Science and Higher Education 2021-12-01
Series:Herba Polonica
Subjects:
Online Access:https://doi.org/10.2478/hepo-2021-0026
_version_ 1797708181670985728
author Przerwa Filip
Kukowka Arnold
Kotrych Katarzyna
Uzar Izabela
author_facet Przerwa Filip
Kukowka Arnold
Kotrych Katarzyna
Uzar Izabela
author_sort Przerwa Filip
collection DOAJ
description Increasing knowledge of the gut microbiota and its interference in human homeostasis in recent years has contributed to a better understanding of number of different interactions occurring in the gastrointestinal tract. Disruption of the microbiota is detrimental to health and contributes to the development of numerous diseases and may also be an accelerator of pathophysiological processes such as atherosclerosis. Cardiovascular diseases are the most common cause of death worldwide, so the development of new methods to support the treatment and prevention of these diseases becoms one of the priorities of modern medicine. Probiotics may constitute an important element of support in the treatment and prevention of CVD (cardiovascular diseases). A number of papers support such a statement, however, larger clinical trials are needed. Through a number of mechanisms including mitigating inflammation, sealing the intestinal epithelium, and affecting metabolism, probiotics may have a beneficial effect on general health and slow down the pathogenesis of many diseases, including those affecting the cardiovascular system. This article contains a review of current discoveries on the role of probiotics in the prevention and support of CVD treatment.
first_indexed 2024-03-12T06:17:35Z
format Article
id doaj.art-4fad5070fbe44b5c8ea3cd4cb3fdc985
institution Directory Open Access Journal
issn 2449-8343
language English
last_indexed 2024-03-12T06:17:35Z
publishDate 2021-12-01
publisher Polish Ministry of Science and Higher Education
record_format Article
series Herba Polonica
spelling doaj.art-4fad5070fbe44b5c8ea3cd4cb3fdc9852023-09-03T02:25:29ZengPolish Ministry of Science and Higher EducationHerba Polonica2449-83432021-12-01674778510.2478/hepo-2021-0026Probiotics in prevention and treatment of cardiovascular diseasesPrzerwa Filip0Kukowka Arnold1Kotrych Katarzyna2Uzar Izabela3Student Science Club, Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, Szczecin, PolandStudent Science Club, Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, Szczecin, PolandDepartment of General and Dental Radiology, Pomeranian Medical University in Szczecin, Szczecin, PolandDepartment of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, Szczecin, PolandIncreasing knowledge of the gut microbiota and its interference in human homeostasis in recent years has contributed to a better understanding of number of different interactions occurring in the gastrointestinal tract. Disruption of the microbiota is detrimental to health and contributes to the development of numerous diseases and may also be an accelerator of pathophysiological processes such as atherosclerosis. Cardiovascular diseases are the most common cause of death worldwide, so the development of new methods to support the treatment and prevention of these diseases becoms one of the priorities of modern medicine. Probiotics may constitute an important element of support in the treatment and prevention of CVD (cardiovascular diseases). A number of papers support such a statement, however, larger clinical trials are needed. Through a number of mechanisms including mitigating inflammation, sealing the intestinal epithelium, and affecting metabolism, probiotics may have a beneficial effect on general health and slow down the pathogenesis of many diseases, including those affecting the cardiovascular system. This article contains a review of current discoveries on the role of probiotics in the prevention and support of CVD treatment.https://doi.org/10.2478/hepo-2021-0026probioticsgastrointestinal diseasesmicrobiota
spellingShingle Przerwa Filip
Kukowka Arnold
Kotrych Katarzyna
Uzar Izabela
Probiotics in prevention and treatment of cardiovascular diseases
Herba Polonica
probiotics
gastrointestinal diseases
microbiota
title Probiotics in prevention and treatment of cardiovascular diseases
title_full Probiotics in prevention and treatment of cardiovascular diseases
title_fullStr Probiotics in prevention and treatment of cardiovascular diseases
title_full_unstemmed Probiotics in prevention and treatment of cardiovascular diseases
title_short Probiotics in prevention and treatment of cardiovascular diseases
title_sort probiotics in prevention and treatment of cardiovascular diseases
topic probiotics
gastrointestinal diseases
microbiota
url https://doi.org/10.2478/hepo-2021-0026
work_keys_str_mv AT przerwafilip probioticsinpreventionandtreatmentofcardiovasculardiseases
AT kukowkaarnold probioticsinpreventionandtreatmentofcardiovasculardiseases
AT kotrychkatarzyna probioticsinpreventionandtreatmentofcardiovasculardiseases
AT uzarizabela probioticsinpreventionandtreatmentofcardiovasculardiseases